American Gene Technologies®
In The News
Washington D.C.’s WONK FM & iHeart Radio Interview Jeff Galvin on Show: Emerging Technology
On May 17, 2019, host Stacy Lyn interviews Jeff Galvin on how AGT is using HIV to cure cancer. The interview aired as part of Wonk FM’s focus on Emerging Technology. Wonk FM | Stacy Lyn | Emerging Technology Back To All Videos & Audios
Read More
Washington Post: “New CDC Chief Stepped Down From Four Groups to Comply With Ethics Rules”
Published by: The Washington Post. Written by: Lena H. Sun Centers for Disease Control and Prevention Director Robert Redfield has resigned his positions at four groups, including a gene therapy biotechnology company and a conservative AIDS organization, to comply with government ethics rules, according to his…
Read More
Wall Street Journal: “New CDC Chief Resigned From Four Entities to Comply With Ethics Rules”
Published by: The Wall Street Journal. Written by: Betsy McKay Updated: April 17, 2018 11:09 am ET Financial disclosures detail steps Robert Redfield has taken; ethics office found him to be in compliance The new director of the Centers for Disease Control and Prevention resigned…
Read More
State Recognizes AGT as a Maryland Success Story
Subscribe to our YouTube Channel Maryland Commercehttps://www.youtube.com/watch?v=alicdhGT_IIPublished on Oct 16, 2018 American Gene Technologies is on a mission to reshape how deadly diseases are treated. CEO Jeff Galvin talks about the company and it’s success in Maryland. Read the success story:https://open.maryland.gov/success-stories/american-gene-technologies/ In the early 2000s,…
Read More
BioWorld: “Report on American Gene Technologies’s Progress Toward an HIV Cure”
Newsletter Vol. 29, No. 18, Pg. 2 January 26, 2018 On January 26, 2018, BioWorld, The Daily Biopharmaceutical Newscource, published this story: American Gene Technologies International Inc. (AGT), of Rockville, Md., disclosed completion of the pilot runs of its HIV cure automated cell processing protocol.…
Read More
Jeff Galvin, AGT CEO, interviewed by Guy Flynn (DLA/Piper Partner) for CityBizList on AGT history, technology and progress
A national media company, CityBizList, published an interview with Jeff Galvin in a three part “CEO Interview” series. Feedback from viewers indicated that it gives an easy-to-understand background and explanation of AGT’s work and mission. If you are interested, you can view the three part…
Read More
Front Line Genomics: “Developing New Treatment Options for Unmet Medical Needs is the Cause That Inspires Us”
Welcome to The Short Read, our weekly peek behind the curtain at the people who make this amazing community tick. Make sure to check back every Tuesday for the latest installment. [two-thirds-first]Julia K. Brown has extensive experience in development-stage pharmaceutical/ biopharmaceutical and commercial-stage specialty pharmaceutical…
Read More
Drug Development & Delivery: “GENE & CELL THERAPY – Its Growing Potential to Disrupt Drug Research & Healthcare Delivery”
Issue: October 2017, Posted Date: 10/2/2017 INTRODUCTION Gene therapy has been emerging for 30 years with the promise of more effectively treating and curing diseases. The basic technology initially used an engineered virus or viral vector to deliver a normal gene to overcome loss of function due to…
Read More
MicroCap Magazine: “AGT in Fall 2017 Edition: Is an HIV Cure Within Our Grasp?”
This biotech company has proprietary technology and therapeutic protocols that are on track to functionally cure HIV-infection and make patients impervious to the HIV virus. AGT’s Protocol AGT is an emerging gene and cell therapy company with an enhanced lentiviral platform capable of addressing a…
Read More
Medium.com: “The Disruption Continues, Thinking Inside the Box About Gene Therapy”
It’s happening… In my previous Medium essay, Disruption for Dummies, I predicted that high-tech gene therapeutics like the ones being developed by American Gene Technologies would not only provide functional cures for scores of deadly diseases, but would do so at significantly lower cost than current forms…
Read MoreSubscribe to News Releases and News Updates
Subscribe to our news release and published article updates to be notified when we release new content!
Follow AGT on Social Media
AGT on Facebook
